Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Palomino Laboratories (PALX) Gains from Sales and Divestitures (2025)

Palomino Laboratories recorded quarterly Gains from Sales and Divestitures of $370834.0 in Q3 2025.

Palomino Laboratories' Gains from Sales and Divestitures history runs 1 years deep, the most recent figure standing at $370834.0 for Q3 2025.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 370,834.00
Sep 30, 2025 370,834.00